Related Experiment Video
Updated: Sep 25, 2025

10:46
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
3.9K
Detection of Cancer-Derived Exosomes Using a Sensitive Colorimetric Aptasensor
Lizhou Xu1,2, Khuloud T Al-Jamal3
1Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, China.
Methods in Molecular Biology (Clifton, N.J.)
|April 25, 2022
Summary
Cancerous exosomes can be detected using a novel colorimetric aptasensor. This biosensor offers a reliable and sensitive method for identifying cancer biomarkers, paving the way for point-of-care diagnostics.
Area of Science:
- Biochemistry
- Nanotechnology
- Molecular Diagnostics
Background:
- Exosomes are extracellular vesicles carrying cellular components like proteins, DNA, and RNA.
- Cancer-derived exosomes serve as promising biomarkers for early cancer detection.
- Biosensors offer sensitive quantification of biomarkers, crucial for clinical applications.
Purpose of the Study:
- To develop a reliable, sensitive, and specific method for detecting cancer-derived exosomes.
- To utilize aptasensors for enhanced exosome analysis and clinical cancer detection.
- To explore the potential of a colorimetric aptasensor for point-of-care testing.
Main Methods:
- Development of a colorimetric aptasensor assay.
- Utilizing aptamers as biorecognition elements for target binding.
- Quantification of cancer-derived exosomes for diagnostic purposes.
Main Results:
- The aptasensor demonstrated reliable and sensitive detection of cancer-derived exosomes.
- The assay showed high specificity in identifying cancer biomarkers.
- The developed method shows promise for point-of-care diagnostic applications.
Conclusions:
- Colorimetric aptasensors provide a viable tool for detecting cancer-derived exosomes.
- This biosensor technology holds significant potential for early cancer diagnosis.
- The assay is suitable for point-of-care testing, improving accessibility to diagnostics.

